Shares of Evoke plc (LON:EVOK - Get Free Report) shot up 0.4% on Friday . The stock traded as high as GBX 51.50 ($0.69) and last traded at GBX 51.10 ($0.69). 527,800 shares changed hands during trading, a decline of 73% from the average session volume of 1,951,333 shares. The stock had previously closed at GBX 50.90 ($0.69).
Wall Street Analysts Forecast Growth
EVOK has been the subject of a number of research analyst reports. Berenberg Bank reiterated a "buy" rating and issued a GBX 95 price target on shares of Evoke in a research note on Thursday, August 21st. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Evoke from GBX 88 to GBX 108 and gave the company a "buy" rating in a report on Wednesday, August 13th. Finally, JPMorgan Chase & Co. reiterated a "neutral" rating on shares of Evoke in a research note on Friday. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of GBX 106.25.
Get Our Latest Stock Report on EVOK
Evoke Stock Up 0.4%
The stock has a market capitalization of £229.79 million, a PE ratio of -203.59 and a beta of 0.84. The firm has a 50 day moving average price of GBX 59.57 and a 200-day moving average price of GBX 56.98.
Evoke (LON:EVOK - Get Free Report) last issued its earnings results on Wednesday, August 13th. The company reported GBX 1.20 EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Equities analysts expect that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Evoke Company Profile
(
Get Free Report)
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.